TAYLOR CARSON: Open Payments
NPI 1619433547 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 18 payments from 9 companies in 2025. Trend: 2023 $181 · 2024 $257 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| ABBVIE INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| SANOFI PASTEUR INC. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
Products named: REXULTI, BREZTRI, MOUNJARO, CAPLYTA, Cologuard Collection Kit, AIRSUPRA, QULIPTA, FLUZONE HIGH-DOSE.
Industry payments across OK — which companies pay providers there.
